Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
07/04/2012 | EP2471516A2 Rhein or diacerein compositions |
07/04/2012 | EP2471515A2 Rhein or diacerein compositions |
07/04/2012 | EP2471514A1 Controlled moisture content of cetyl myristate and/or cetyl palmitate granules or formulations |
07/04/2012 | EP2471513A1 Process for producing an active pharmaceutical ingredient (API) preparation in the form of beads |
07/04/2012 | EP2471512A2 Non-polar photosensitizer formulations for photodynamic therapy |
07/04/2012 | EP2471511A1 Liposome formulation suitable for treating or preventing tuberculosis |
07/04/2012 | EP2471510A1 Liquid formulation of G-CSF |
07/04/2012 | EP2471509A1 Methods and Ophthalmic Devices used in the Treatment of Ocular Allergies |
07/04/2012 | EP2471508A1 Methods and Ophthalmic Devices used in the Treatment of Ocular Allergies |
07/04/2012 | EP2471507A1 Methods and Ophthalmic Devices used in the Treatment of Ocular Allergies |
07/04/2012 | EP2471387A1 Cetyl myristate and/or cetyl palmitate suspension formulations |
07/04/2012 | EP2471386A1 Cetyl myristate and/or cetyl palmitate suspension formulations |
07/04/2012 | EP2471385A1 Cetyl myristate and/or cetyl palmitate suspension formulations |
07/04/2012 | EP2471384A1 Suspension formulations of cetyl myristate and/or cetyl palmitate |
07/04/2012 | EP2470534A1 Jak inhibition blocks rna interference associated toxicities |
07/04/2012 | EP2470223A2 Sprayable polymers as adhesion barriers |
07/04/2012 | EP2470193A1 Synthesis of oxygen carrying, turbulence resistant, high density submicron particulates |
07/04/2012 | EP2470186A2 Synthesis and isolation of dendrimer systems |
07/04/2012 | EP2470179A2 Sustained release delivery systems for the prevention and treatment of head and neck cancers |
07/04/2012 | EP2470173A1 Combination therapy with nanoparticle compositions of taxane and hedgehog inhibitors |
07/04/2012 | EP2470172A1 Pharmaceutical formulations and methods of use |
07/04/2012 | EP2470167A2 Methods and systems for dosing and coating inhalation powders onto carrier particles |
07/04/2012 | EP2470166A2 New compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine |
07/04/2012 | EP2470165A1 Film coating composition from solid powder compounds |
07/04/2012 | EP2470164A2 Liposomal compositions and uses of same |
07/04/2012 | EP2470163A2 Methods and compositions for delivering interleukin-1 receptor antagonist |
07/04/2012 | EP2470162A2 Implantable device for production of interleukin-1 receptor antagonist |
07/04/2012 | EP2470157A1 Hot-melt extruded compositions containing plant-derived phenolic materials and processes for the preparation thereof |
07/04/2012 | EP2254952B1 Pharmaceutical dye extracted from cranberry with high proanthocyanidin a concentration |
07/04/2012 | EP2229150B1 Systems and methods for delivery of materials |
07/04/2012 | EP2194798B1 Particle stabilised emulsion composition |
07/04/2012 | EP2066307B1 Rapidly disintegrating dosage form |
07/04/2012 | EP1942938B1 Use of oligouronates for treating mucus hyperviscosity |
07/04/2012 | EP1928436B1 Application system for a plaster containing an active ingredient and a controlled-release agent for said active ingredient |
07/04/2012 | EP1868569B1 Liquid aqueous dosage forms for sub-lingual or nasal applications of active agents with amino groups |
07/04/2012 | EP1830802B1 Effervescent pressed chewing gum tablet compositions |
07/04/2012 | EP1732522B1 Gastric retention system |
07/04/2012 | EP1720528B1 Layered silicate nanoparticle-polymer composite medical articles |
07/04/2012 | EP1697398B1 Aqueous suspensions of ciclesonide for nebulisation |
07/04/2012 | EP1684731B1 Film-forming starchy composition |
07/04/2012 | EP1624869B1 Dosage form containing pantoprazole as active ingredient |
07/04/2012 | EP1485094B1 Dosage form for oral administration of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester or its salts |
07/04/2012 | EP1439858B1 Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions |
07/04/2012 | EP1349580B2 Process to improve stability of a pharmaceutical composition |
07/04/2012 | EP1051174B2 Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations |
07/04/2012 | DE212011100034U1 Material zur Behandlung von inneren Hohlräumen Material for the treatment of internal cavities |
07/04/2012 | CN202288922U 精制中药饮片 Refined Chinese Herbal Medicine |
07/04/2012 | CN202288921U Compound naproxen esomeprazole tablet |
07/04/2012 | CN202288920U 复合软胶囊酊贴 Compound tincture of soft capsules paste |
07/04/2012 | CN202288919U 一种缓释高吸收新型湿敷贴 A slow-release high absorption of new wet paste |
07/04/2012 | CN202288918U 儿童吃药糖衣球 Children's medicine ball icing |
07/04/2012 | CN202288917U 一种定量压制中药饮片或中药材 A quantitative or medicines to suppress Chinese Herbal Medicine |
07/04/2012 | CN1964703B Immediate release pharmaceutical tablets with height greater than width |
07/04/2012 | CN1958608B Method for preparing specificity IgY of anti influenza of birds, and preparation |
07/04/2012 | CN1947752B Concentrated medicine pills contg. bighead atractylodes rhizome and trifoliate orange seeds and its prepn. method |
07/04/2012 | CN1857497B Erosion treating Chinese medicine ointment and its quality control method |
07/04/2012 | CN1845783B Method for production of enzyme granules and enzyme granules produced thus |
07/04/2012 | CN1842321B Bioerodible sustained release drug delivery systems |
07/04/2012 | CN1736413B Finely prepared sustained-releasing formulation for coronary disease and preparation process thereof |
07/04/2012 | CN1713897B Sustained release preparation |
07/04/2012 | CN1536986B Intravaginal drug delivery devices for administration of antimicrobial agent |
07/04/2012 | CN102549143A Extracellular vesicles derived from gram-positive bacteria, and use thereof |
07/04/2012 | CN102549034A Hybrid copolymer compositions for personal care applications |
07/04/2012 | CN102549029A Pellets coated with coatings containing active substances |
07/04/2012 | CN102548582A Eye drops |
07/04/2012 | CN102548580A Solutions comprising polyethylene glycol and electrolytes |
07/04/2012 | CN102548575A Eye drops |
07/04/2012 | CN102548562A Ophthalmic composition |
07/04/2012 | CN102548556A Tablet |
07/04/2012 | CN102548546A Transdermal therapeutic system for administering fentanyl or an analogue thereof |
07/04/2012 | CN102548545A Multi-layer transdermal patch |
07/04/2012 | CN102548544A Pharmaceutical composition with both immediate and extended release characteristics |
07/04/2012 | CN102548543A Slow-release cilostazol tablet having an improved elution rate and minimal side effects |
07/04/2012 | CN102548542A Tablet that disintegrates rapidly in the mouth and that contains two or more types of particles |
07/04/2012 | CN102548541A Floating microgranules |
07/04/2012 | CN102548540A Solid pharmaceutical preparations comprising amphiphilic copolymers on the basis of polyethers in combination with surfactants |
07/04/2012 | CN102548539A Pharmaceutical compositions for the treatment of cancer and other diseases or disorders |
07/04/2012 | CN102548538A Topical formulation for diabetic foot ulcers |
07/04/2012 | CN102548537A Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate |
07/04/2012 | CN102548536A Olopatadine compositions and uses thereof |
07/04/2012 | CN102548535A Sublingual and buccal film compositions |
07/04/2012 | CN102532569A Preparation method of yak milk casein edible film |
07/04/2012 | CN102532564A Hydrogel and preparation method thereof |
07/04/2012 | CN102532533A Poly(aspartic acid-co-lactic acid)-phosphatidyl ethanolamine graft polymer and preparation method and application thereof |
07/04/2012 | CN102532262A Preparation of fatty acid-RGD-fatty alcohol conjugate mediated epirubicin targeted liposome and evaluation on anticancer activity |
07/04/2012 | CN102532259A Oligopeptide-based cationic lipid derivative and application thereof in pharmaceutical preparation |
07/04/2012 | CN102526796A Absorbable haemostatic material prepared based on rat tail collagen and preparation method of same |
07/04/2012 | CN102526774A Capsules for displaying pathological changes in left adnexal area conveniently |
07/04/2012 | CN102526771A Invisible nano-liposome injection for encapsulating USPIO (Ultra-small Super Paramagnetic Iron Oxide) and preparation method and application thereof |
07/04/2012 | CN102526760A Recombinant attenuated salmonella vaccine and pharmaceutical composition for treating solid tumors and application thereof |
07/04/2012 | CN102526759A Dendritic-polymer-based high-bioavailability oral puerarin preparation |
07/04/2012 | CN102526758A Stable aqueous solution of pegylation interferon |
07/04/2012 | CN102526756A Adriamycin composite, micelle and preparation method for micelle |
07/04/2012 | CN102526755A Reducibly biodegradable release controlled camptothecin nano micelle pre-medicament and preparation method |
07/04/2012 | CN102526754A Application of gum extracted from Abelmoschus manihot as matrix of Chinese medicinal gel |
07/04/2012 | CN102526753A In-situ phase change gel slow release system taking phospholipid as substrate and preparation method thereof |
07/04/2012 | CN102526752A Bitterness-eliminated medicinal preparation |
07/04/2012 | CN102526750A Plant colonic-coated hollow capsule |
07/04/2012 | CN102526749A Pharmaceutical composition comprising porous dry matrix |
07/04/2012 | CN102526748A Oral tablet containing valsartan, hydrochlorothiazide and amlodipine besylate |